Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionClaro Advisors LLC
Latest Disclosed Ownership2,291 shares
Latest Disclosed Value $ 349,958
Claro Advisors LLC reports 9.36% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 21, 2026 - Claro Advisors LLC filed a 13F-HR form disclosing ownership of 2,291 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $349,950 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,095 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 9.36% during the quarter. The current value of the position is $329,125 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,291 196 9.36 350 21.18 0.0422
2026-02-17 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,095 -41 -1.92 289 5.49 0.0394
2025-11-12 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,136 -74 -3.35 274 2.25 0.0400
2025-08-05 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,210 91 4.29 267 13.14 0.0442
2025-05-12 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,119 -1,835 -46.41 236 -38.54 0.0316
2025-01-13 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,954 -684 -14.75 385 -27.95 0.0520
2024-11-07 2024-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 4,638 4,638 533 0.0689
2024-10-17 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 9,755 9,755 878 0.1135
2023-03-10 2022-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 0 -4,695 -100.00 0 -100.00
2023-02-14 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 0 -4,695 0
2022-11-18 2022-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 4,695 0 0.00 397 0.00 0.1578
2022-11-14 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 4,695 0 397 0.1578
2022-08-12 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 4,695 1,828 63.76 397 58.17 0.1578
2022-05-16 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,867 0 0.00 251 0.00 0.0903
2022-02-14 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,867 -77 -2.62 251 4.15 0.0903
2021-11-15 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,944 243 9.00 241 -2.03 0.1014
2021-08-13 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,701 -1 -0.04 246 6.49 0.1107
2021-05-17 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,702 190 7.56 231 -2.53 0.1170
2021-02-12 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,512 -668 -21.01 237 -14.44 0.1260
2020-11-16 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,180 107 3.48 277 3.36 0.1755
2020-08-14 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,073 301 10.86 268 17.03 0.1844
2020-05-15 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,772 289 11.64 229 -2.55 0.2135
2020-02-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,483 44 1.80 235 10.85 0.1809
2019-10-29 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,439 65 2.74 212 -2.30 0.1881
2019-07-24 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,374 -81 -3.30 217 -8.05 0.2003
2019-05-10 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,455 1,010 69.90 236 88.80 0.2335
2019-02-14 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,445 1,445 125 0.1001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.